Featured Archives

Cyclacel Pharmaceuticals (NASDAQ: CYCC) Sees Significant Stock Volatility Amid New Financing...

Kate Hudson - May 1, 2024 0

GeneDx Holdings Corp. (WGS) Bolsters Financial and Strategic Position in 2024

Kate Hudson - April 30, 2024 0

Wall Street Bulls Eye a 290% Upside on Actinium Pharmaceuticals, Inc....

admin - April 1, 2024 0

Mesoblast’s (NASDAQ: MESO) Breakthrough: A New Horizon in Pediatric Treatment Sparks...

Ward Sport - March 29, 2024 0

Merck Secures FDA Approval for Winrevair, Revolutionizing Treatment for Pulmonary Arterial...

Kate Hudson - March 26, 2024 0

12 3...44 Page 1 of 44

Harmony Biosciences (HRMY) : Charting a Course for Sustained Growth

Matt Wade - September 20, 2024 0

Harmony Biosciences (NASDAQ: HRMY) recently released its Q2 2024 earnings, demonstrating robust growth and strategic progress. The company reported a 29% year-over-year...

Halozyme’s ENHANZE® (HALO) Technology Empowers OCREVUS ZUNOVO™: A New Era in...

September 20, 2024

Anebulo Pharmaceuticals Secures NIH Grant for Emergency Cannabis Antidote Development

September 20, 2024

Applied Therapeutics Surges on Positive FDA Update for Govorestat

September 18, 2024

Portage Biotech (PRTG): Wild Ride Continues, But Uncertainty Looms

September 18, 2024

Featured

Recent Post